Affiliation:
1. Princess Tharwat University College, affiliated to Balqa Applied University, Muhawish Yusuf, Amman, Jordan.
Abstract
COVID-19 is an infectious disease caused by a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus originated from Wuhan city, which spread rapidly throughout the world after it hit China in December 2019 and became a global pandemic. There are two significant classes of the Coronavirus affecting human beings: SARS and MERS. Coronavirus is a positive-sense virus, an RNA virus with a single strand of RNA. And gets its title from the crown-like spikes on their surface. Presently, testing for COVID-19 is done by taking a nasal swab, tracheal aspirate, or bronchoalveolar samples and there are different conventional techniques are available for the detection like CT-scan, PCR, Sequencing, CRISPR, ELISA, LFA, LAMP, RT-PCR, and Rapid Antigen Test. COVID-19 treatment generally depends on the severity and/or the health status of the infected patient. The treatment procedure, at the beginning of the pandemic, includes the use of antiviral drugs which have limited availability. And clinical trials of vaccines are going on by different companies and some are released at the beginning of the COVID-19 currently, 10 vaccines are approved by the WHO. As more clinical examinations continue to be done, the availability of antivirals increases as well as vaccines. Preventive measures are social/physical distancing, masking, and isolation of infected individuals. There is an immense need to consider elective available resources to boost one’s immune system along with probiotics. Along with diminishing the pressure by expanding exercise and meditation. Although educational systems have used different learning management systems, there are concerns about the online teaching system in comparison to the traditional classroom teaching system. Our objective has been to examine the effects of COVID-19 on health systems globally and various aspects of human life as well.
Publisher
Oriental Scientific Publishing Company
Subject
Drug Discovery,Agronomy and Crop Science,Biotechnology
Reference58 articles.
1. 1. Kupferschmidt, K., and Cohen, J. (2020). Can China’s COVID-19 strategy work elsewhere? Science, 367,1061–2. doi: 10.1126/science.367.6482.1061.
2. 2. Deng, S. Q., and Peng, H. J. (2020). Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. Journal of Clinical Medicine, 9(2), 575. doi: 10.3390/jcm9020575.
3. 3. Spector-Bagdady, K. (2020). Hospitals should act now to notify patients about research use of their data and biospecimens. Nature Medicine, 26(3), 306-308. doi: 10.1038/s41591-020-0795-6.
4. 4. Lewis, IK., Zhou, M., and Wang, EJY. (2020). The China Experience – Understanding the Evolution of the COVID-19 Crisis: Perspectives & Events: Mayer Brown,” Perspectives & Event Mayer Brown, Retrieved November 01, 2020, from https://www.mayerbrown.com/en/perspectives-events/publications/2020/03/the-china-experience-understanding-the-evolution-of-the-covid-19-crisis.
5. 5. Kraemer, M. U., Yang, C. H., Gutierrez, B., Wu, C. H., Klein, B., Pigott, D. M., … Brownstein, J. S. (2020). The effect of human mobility and control measures on the COVID-19 epidemic in China. Science, 368(6490), 493-497. doi: 10.1126/science. abb4218.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献